Skip to main content
Erschienen in: Pathology & Oncology Research 3/2018

29.06.2017 | Original Article

Intratumoral Heterogeneity of Frameshift Mutations of GLI1 Encoding a Hedgehog Signaling Protein in Colorectal Cancers

verfasst von: Ju Hwa Lee, Sang Yong Song, Min Sung Kim, Nam Jin Yoo, Sug Hyung Lee

Erschienen in: Pathology & Oncology Research | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

GLI1 is a transcription factor for hedgehog signaling that plays a crucial role in signaling pathways for controlling cell proliferation, alterations of which are known to contribute to tumorigenesis. Aim of this study was to explore whether GLI1 gene is mutated in gastric (GC) and colorectal cancers (CRC). In a public database, we found that GLI1 had a G7 mononucleotide repeat in the coding sequences that could be a mutation target in the cancers with microsatellite instability (MSI). In this study, we analyzed frameshift mutation of GLI1 in 79 GCs and 129 CRCs (high MSI (MSI-H) or microsatellite stable (MSS)) by single-strand conformation polymorphism analysis and DNA sequencing. We found 10 frameshift mutations in the repeat, nine for CRCs and one for GC. All of the mutations were detected in cancers with MSI-H and there was a statistical difference in the frameshift mutation frequencies between the cancers with MSI-H (10/113) and MSS (0/90). We also analyzed intratumoral heterogeneity (ITH) of the frameshift mutation in 16 CRCs and found that the mutations exhibited regional ITH in three of the CRCs (18.8%). Our data indicate GLI1 harbored not only frameshift mutation but also its mutational ITH, which together could be a feature of GC and CRC with MSI-H.
Literatur
1.
Zurück zum Zitat Lim L, Beachy PA (2004) The hedgehog response network: sensors, switches, and routers. Science 304:1755–1759CrossRef Lim L, Beachy PA (2004) The hedgehog response network: sensors, switches, and routers. Science 304:1755–1759CrossRef
2.
Zurück zum Zitat Ruiz i Altaba A (1999) Gli proteins encode context-dependent positive and negative functions: implications for development and disease. Development 126:3205–3216PubMed Ruiz i Altaba A (1999) Gli proteins encode context-dependent positive and negative functions: implications for development and disease. Development 126:3205–3216PubMed
3.
Zurück zum Zitat Villavicencio EH, Walterhouse DO, Iannaccone PM (2000) The sonic hedgehog-patched-gli pathway in human development and disease. Am J Hum Genet 67:1047–1054CrossRefPubMedPubMedCentral Villavicencio EH, Walterhouse DO, Iannaccone PM (2000) The sonic hedgehog-patched-gli pathway in human development and disease. Am J Hum Genet 67:1047–1054CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Sanchez P, Clement V, Ruiz i Altaba A (2005) Therapeutic targeting of the hedgehog-GLI pathway in prostate cancer. Cancer Res 65:2990–2992CrossRefPubMed Sanchez P, Clement V, Ruiz i Altaba A (2005) Therapeutic targeting of the hedgehog-GLI pathway in prostate cancer. Cancer Res 65:2990–2992CrossRefPubMed
6.
Zurück zum Zitat Hui CC, Angers S (2011) Gli proteins in development and disease. Annu Rev Cell Dev Biol 27:513–537CrossRefPubMed Hui CC, Angers S (2011) Gli proteins in development and disease. Annu Rev Cell Dev Biol 27:513–537CrossRefPubMed
7.
Zurück zum Zitat Rubin JB, Rowitch DH (2002) Medulloblastoma: a problem of developmental biology. Cancer Cell 2:7–8CrossRefPubMed Rubin JB, Rowitch DH (2002) Medulloblastoma: a problem of developmental biology. Cancer Cell 2:7–8CrossRefPubMed
8.
Zurück zum Zitat Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O'Brien SJ, Wong AJ, Vogelstein B (1987) Identification of an amplified, highly expressed gene in a human glioma. Science 236:70–73CrossRefPubMed Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O'Brien SJ, Wong AJ, Vogelstein B (1987) Identification of an amplified, highly expressed gene in a human glioma. Science 236:70–73CrossRefPubMed
9.
Zurück zum Zitat Oniscu A, James RM, Morris RG, Bader S, Malcomson RD, Harrison DJ (2004) Expression of sonic hedgehog pathway genes is altered in colonic neoplasia. J Pathol 203:909–917CrossRefPubMed Oniscu A, James RM, Morris RG, Bader S, Malcomson RD, Harrison DJ (2004) Expression of sonic hedgehog pathway genes is altered in colonic neoplasia. J Pathol 203:909–917CrossRefPubMed
10.
Zurück zum Zitat Imai K, Yamamoto H (2008) Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis 29:673–680CrossRefPubMed Imai K, Yamamoto H (2008) Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis 29:673–680CrossRefPubMed
11.
Zurück zum Zitat Calin GA, Gafà R, Tibiletti MG, Herlea V, Becheanu G, Cavazzini L, Barbanti-Brodano G, Nenci I, Negrini M, Lanza G (2000) Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: a study of the TGRbetaRII, BAX, hMSH3, hMSH6, IGFIIR and BLM genes. Int J Cancer 89:230–235CrossRefPubMed Calin GA, Gafà R, Tibiletti MG, Herlea V, Becheanu G, Cavazzini L, Barbanti-Brodano G, Nenci I, Negrini M, Lanza G (2000) Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: a study of the TGRbetaRII, BAX, hMSH3, hMSH6, IGFIIR and BLM genes. Int J Cancer 89:230–235CrossRefPubMed
12.
Zurück zum Zitat Marusyk A, Almendro V, Polyak K (2012) Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 12:323–334CrossRefPubMed Marusyk A, Almendro V, Polyak K (2012) Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 12:323–334CrossRefPubMed
13.
Zurück zum Zitat Murphy K, Zhang S, Geiger T, Hafez MJ, Bacher J, Berg KD, Eshleman JR (2006) Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers. J Mol Diagn 8:305–311CrossRefPubMedPubMedCentral Murphy K, Zhang S, Geiger T, Hafez MJ, Bacher J, Berg KD, Eshleman JR (2006) Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers. J Mol Diagn 8:305–311CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Jo YS, Choi MR, Song SY, Kim MS, Yoo NJ, Lee SH (2016) Frameshift mutations of HSPA4 and MED13 in gastric and colorectal cancers. Pathol Oncol Res 22:769–772CrossRefPubMed Jo YS, Choi MR, Song SY, Kim MS, Yoo NJ, Lee SH (2016) Frameshift mutations of HSPA4 and MED13 in gastric and colorectal cancers. Pathol Oncol Res 22:769–772CrossRefPubMed
15.
Zurück zum Zitat Jo YS, Kim MS, Yoo NJ, Lee SH (2016) Absence of PRKD1 mutation, a salivary tumor-specific mutation, in solid tumors and Leukemias. Pathol Oncol Res 22:231–232CrossRefPubMed Jo YS, Kim MS, Yoo NJ, Lee SH (2016) Absence of PRKD1 mutation, a salivary tumor-specific mutation, in solid tumors and Leukemias. Pathol Oncol Res 22:231–232CrossRefPubMed
16.
Zurück zum Zitat Choi EJ, Kim MS, Song SY, Yoo NJ, Lee SH (2017) Intratumoral heterogeneity of frameshift mutations in MECOM Gene is frequent in colorectal cancers with high microsatellite instability. Pathol Oncol Res 23:145–149CrossRefPubMed Choi EJ, Kim MS, Song SY, Yoo NJ, Lee SH (2017) Intratumoral heterogeneity of frameshift mutations in MECOM Gene is frequent in colorectal cancers with high microsatellite instability. Pathol Oncol Res 23:145–149CrossRefPubMed
17.
18.
Zurück zum Zitat Lee SW, Moskowitz MA, Sims JR (2007) Sonic hedgehog inversely regulates the expression of angiopoietin-1 and angiopoietin-2 in fibroblasts. Int J Mol Med 19:445–451PubMed Lee SW, Moskowitz MA, Sims JR (2007) Sonic hedgehog inversely regulates the expression of angiopoietin-1 and angiopoietin-2 in fibroblasts. Int J Mol Med 19:445–451PubMed
19.
Zurück zum Zitat Adolphe C, Hetherington R, Ellis T, Wainwright B (2006) Patched1 functions as a gatekeeper by promoting cell cycle progression. Cancer Res 66:2081–2088CrossRefPubMed Adolphe C, Hetherington R, Ellis T, Wainwright B (2006) Patched1 functions as a gatekeeper by promoting cell cycle progression. Cancer Res 66:2081–2088CrossRefPubMed
20.
Zurück zum Zitat Athar M, Li C, Tang X, Chi S, Zhang X, Kim AL, Tyring SK, Kopelovich L, Hebert J, Epstein EH Jr, Bickers DR, Xie J (2004) Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis. Cancer Res 64:7545–7552CrossRefPubMed Athar M, Li C, Tang X, Chi S, Zhang X, Kim AL, Tyring SK, Kopelovich L, Hebert J, Epstein EH Jr, Bickers DR, Xie J (2004) Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis. Cancer Res 64:7545–7552CrossRefPubMed
21.
Zurück zum Zitat Choi YJ, Kim MS, An CH, Yoo NJ, Lee SH (2014) Regional bias of intratumoral genetic heterogeneity of nucleotide repeats in colon cancers with microsatellite instability. Pathol Oncol Res 20:965–971CrossRefPubMed Choi YJ, Kim MS, An CH, Yoo NJ, Lee SH (2014) Regional bias of intratumoral genetic heterogeneity of nucleotide repeats in colon cancers with microsatellite instability. Pathol Oncol Res 20:965–971CrossRefPubMed
22.
Zurück zum Zitat Choi YJ, Rhee JK, Hur SY, Kim MS, Lee SH, Chung YJ, Kim TM, Lee SH (2017) Intraindividual genomic heterogeneity of high-grade serous carcinoma of the ovary and clinical utility of ascitic cancer cells for mutation profiling. J Pathol 241:57–66CrossRefPubMed Choi YJ, Rhee JK, Hur SY, Kim MS, Lee SH, Chung YJ, Kim TM, Lee SH (2017) Intraindividual genomic heterogeneity of high-grade serous carcinoma of the ovary and clinical utility of ascitic cancer cells for mutation profiling. J Pathol 241:57–66CrossRefPubMed
Metadaten
Titel
Intratumoral Heterogeneity of Frameshift Mutations of GLI1 Encoding a Hedgehog Signaling Protein in Colorectal Cancers
verfasst von
Ju Hwa Lee
Sang Yong Song
Min Sung Kim
Nam Jin Yoo
Sug Hyung Lee
Publikationsdatum
29.06.2017
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 3/2018
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-017-0272-9

Weitere Artikel der Ausgabe 3/2018

Pathology & Oncology Research 3/2018 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.